Megestrol Acetate Suspension
Product Images NDC 17856-0060

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Megestrol Acetate (NDC 17856-0060). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Atlantic Biologicals Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (17856 0060 01)

This is a description of a medication with the following details: the product is MEGESTROL ACETATE LDEEE; it is an ORAL SUSPENSION, USP with a strength of 400 MG/10 ML; each package contains 72 cups of the medication; the medication should be stored at a temperature between 20° to 25°C; the package has a specific lot number, an expiration date of 11/03/22, and a GTIN of 00117856005015. Additionally, it is indicated to keep this and all drugs out of reach of children. The package was distributed by Atlantic Biologicals Corp, and there is a contact number to reorder.*

FDA Label Image

Image Description (17856 0060 02)

MEGESTROL ACETATE LIDCIEE Oral suspension,USP with a strength of 800mg/20mL. This package provides 50 cups with an expiration date of 11/03/22 and a lot number of 017550. It is necessary to store this oral suspension at a temperature between 20 to 25°C. The package contains a package insert that provides indications and dosage schedules. It is important to keep the medication out of reach of children. Packaged by Unit Dase Solutions and distributed by AtariicBilogicals Corp, Morisile, NC 27580 Miary FI33179. A phone number (800.509.7592) is also provided for reordering purposes.*

FDA Label Image

Chemical Formula (63aedf9e 8b0a 4dcc 8fa6 5c7dc4c776d3 01)

megestrol acetate, USP is a medication used to treat breast cancer, endometrial cancer, and appetite loss in people with cancer or acquired immunodeficiency syndrome (AIDS).*

FDA Label Image

Trial 1 (63aedf9e 8b0a 4dcc 8fa6 5c7dc4c776d3 02)

FDA Label Image

Trial 2 (63aedf9e 8b0a 4dcc 8fa6 5c7dc4c776d3 03)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.